Berdikari Pondasi Perkasa Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Berdikari Pondasi Perkasa Tbk trades at Rp144 (market cap 689.86B, 8.95M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp244 (market cap 164.65B, 214.9K 24h volume). The key difference: Berdikari Pondasi Perkasa Tbk is far larger — about 4.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Berdikari Pondasi Perkasa Tbk is more actively traded (8.95M versus 214.9K). Which is the better fit depends on your goals.
| BDKR | OBAT | |
|---|---|---|
Market Cap | 689.86B | 164.65B |
Volume | 8.95M | 214.9K |
Lot | 89.48K | 2.15K |
Turnover | 1.29B | 51.97M |
Average Price | 143.89 | 241.85 |
Value | 1.29B | 51.97M |
Indicative Equilibrium Price | 144 | 240 |
Indicative Equilibrium Volume | 75 | 100 |
Trailing returns across standard periods
Latest headlines on both assets
PT Berdikari Pondasi Perkasa Tbk (the “Company”) was established on February 27, 1984 based onNotarial Deed No. 81 of Gretha Liestijawatie, S.H. The Company started its commercial operations onFebruary 27, 1984. The controlling interest of the Company is owned by an individual namely Tan John Tanuwijaya.
Read more on BDKR →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →